Logo wahanariau.com
  2. Boehringer ingelheim

Boehringer ingelheim

Index
Globenewswire

Boehringer Ingelheim Partners with NCD Alliance to Target Non-Communicable Diseases in Underserved Communities

Jumat, 27 September 2024 - 22:47:56 Wib
Globenewswire

Boehringer Ingelheim Expands Cancer Research at its Vienna Site

Rabu, 25 September 2024 - 22:00:00 Wib
Globenewswire

Boehringer’s Nerandomilast Meets Primary Endpoint in Pivotal Phase-III FIBRONEER™-IPF Study

Senin, 16 September 2024 - 17:30:00 Wib
Globenewswire

Boehringer’s Zongertinib Shows Encouraging Efficacy and Tolerability Profile in Previously Treated HER2 Mutated Lung Cancer Patients

Selasa, 10 September 2024 - 04:39:42 Wib
Globenewswire

Boehringer Ingelheim Announces Plans to Advance Potential New Treatment for Geographic Atrophy, Following Positive Phase I Results

Kamis, 05 September 2024 - 22:00:00 Wib
Globenewswire

Boehringer Ingelheim Acquires Saiba Animal Health, Adding Innovative Technology Platform to its Pet Therapeutics R&D Portfolio

Selasa, 03 September 2024 - 14:10:00 Wib
Globenewswire

Boehringer Ingelheim to Unveil Groundbreaking Oncology Research at WCLC, Demonstrating Strength of Portfolio

Selasa, 27 Agustus 2024 - 14:30:00 Wib
Globenewswire

CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for SPEVIGO®

Senin, 29 Juli 2024 - 13:30:00 Wib
Globenewswire

First half of 2024: Boehringer Ingelheim Progresses Pipeline at Pace and Reaches Major Milestones

Kamis, 18 Juli 2024 - 14:30:00 Wib
Globenewswire

Boehringer Ingelheim Produces its Own Green Energy

Selasa, 09 Juli 2024 - 20:53:12 Wib
Globenewswire

Outdated Perceptions and Practices Fuelling Mental Health Crisis, New Economist Impact Study Reveals

Rabu, 29 Mei 2024 - 22:01:21 Wib
Globenewswire

Boehringer Ingelheim Shares Positive Results from the First Study Worldwide in Diabetic Macular Ischemia

Selasa, 07 Mei 2024 - 10:26:16 Wib
Globenewswire

Less than Half of Veterinary Professionals Feel Their Profession is Appreciated

Jumat, 26 April 2024 - 03:51:07 Wib
Globenewswire

Boehringer Ingelheim Reports Strong Growth in 2023 and Accelerates Late-stage Pipeline

Rabu, 17 April 2024 - 05:27:28 Wib
Globenewswire

SPEVIGO® Approved for Expanded Indications in China and the US

Rabu, 20 Maret 2024 - 05:30:38 Wib
Globenewswire

Survodutide Phase II Trial Shows 83% of Adults Treated Achieved Groundbreaking Results in Liver Disease Due to MASH, with Significant Improvements in Fibrosis

Selasa, 27 Februari 2024 - 04:51:28 Wib
Globenewswire

New Collaboration Between Boehringer Ingelheim and Sleip Leverages AI-technology to help Detect Lameness in Horses

Senin, 19 Februari 2024 - 16:30:00 Wib
Globenewswire

Boehringer Expands Production Site in Greece for New Medicine

Kamis, 11 Januari 2024 - 22:30:00 Wib